original ) (raw )Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity
Vinay Sridhar
International journal of biological macromolecules, 2017
View PDFchevron_right
Development and in vitro safety evaluation of pramipexole-loaded hollow mesoporous silica (HMS) particles
Denitsa Aluani
Biotechnology & Biotechnological Equipment, 2019
View PDFchevron_right
Development and in vitro safety evaluation of pramipexole-loaded hollow mesoporous silica (HMS) particles
Denitsa Aluani
Biotechnology & Biotechnological Equipment, 2019
View PDFchevron_right
Fabrication and in vitro characterization of polymeric nanoparticles for Parkinson's therapy: a novel approach
Shubhini Saraf
Brazilian Journal of Pharmaceutical Sciences, 2014
View PDFchevron_right
Development of Nanosized, Pramipexole-Encapsulated Liposomes and Niosomes for the Treatment of Parkinson’s Disease
Yekta Özer
Journal of Nanoscience and Nanotechnology, 2017
View PDFchevron_right
Nanotechnology-based drug delivery of ropinirole for Parkinson’s disease
Luis García
Drug Delivery, 2017
View PDFchevron_right
New-Fangled Approach in the Management of Alzheimer by Formulation of Polysorbate 80 Coated Chitosan Nanoparticles of Rivastigmine for Brain Delivery and their in Vivo Evaluation
ISIJ Publication
View PDFchevron_right
Pramipexole Dihydrochloride Loaded Mpegpcl Nanosuspension by Modified Nanoprecipitation: In Vitro and in Vivo Evaluation
Soma Sundaram
Asian Journal of Pharmaceutical and Clinical Research, 2016
View PDFchevron_right
Neuroprotective Investigation of Chitosan Nanoparticles for Dopamine Delivery
Anna Giudetti
Applied Sciences
View PDFchevron_right
Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery
Silvana Gaetani
International Journal of Pharmaceutics, 2011
View PDFchevron_right
Preparation of novel tissue acidosis‐responsive chitosan drug nanoparticles: Characterization and in vitro release properties of Ca2+ channel blocker nimodipine drug molecules
Ádám Juhász
2018
View PDFchevron_right
DPPC:MPOx chimeric advanced Drug Delivery nano Systems (chi-aDDnSs): Physicochemical and structural characterization, stability and drug release studies
Stergios Pispas
International Journal of Pharmaceutics, 2013
View PDFchevron_right
Chitosan coated synergistically engineered nanoemulsion of Ropinirole and nigella oil in the management of Parkinson's disease: Formulation perspective and In vitro and In vivo assessment
Ankita Pathak
International Journal of Biological Macromolecules, 2021
View PDFchevron_right
New Candidate Delivery System for Alzheimer’s Disease: Deferoxamine Nanogels
Amir Azadi
Biointerface Research in Applied Chemistry, 2020
View PDFchevron_right
{"__content__"=>"Preparation of novel tissue acidosis-responsive chitosan drug nanoparticles: Characterization and in vitro release properties of Ca channel blocker nimodipine drug molecules.", "sup"=>{"__content__"=>"2+"}}
Ádám Juhász
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018
View PDFchevron_right
Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization
Stefania Cometa
Analytical and Bioanalytical Chemistry, 2011
View PDFchevron_right
New method for preparation of delivery systems of poorly soluble drugs on the basis of functionalized mesoporous MCM-41 nanoparticles
Hristiyan Aleksandrov
Microporous and Mesoporous Materials, 2014
View PDFchevron_right
Preparation and characterization of L – Dopa loaded chitosan – based dry powder: Rescue / continuous supplement in Parkinson's disease via inhalation
World Journal of Pharmaceutical Sciences
View PDFchevron_right
Synthesis and characterization of cystamine conjugated chitosan-SS-mPEG based 5-Fluorouracil loaded polymeric nanoparticles for redox responsive drug release
Angelin Tisha
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2017
View PDFchevron_right
Physical and Chemical Strategies for Therapeutic Delivery by Using Polymeric Nanoparticles
Adah Almutairi
Pharmacological Reviews, 2012
View PDFchevron_right
The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems
deepa nakmode
Pharmaceutics
View PDFchevron_right
Chitosan modified mesoporous silica nanoparticles as a versatile drug carrier with pH dependent properties
Lannie Hadisoewignyo
EXPLORING RESOURCES, PROCESS AND DESIGN FOR SUSTAINABLE URBAN DEVELOPMENT: Proceedings of the 5th International Conference on Engineering, Technology, and Industrial Application (ICETIA) 2018
View PDFchevron_right
Novel anionic polymer as a carrier for CNS delivery of anti-Alzheimer drug
Dr. Raj Nagarkar
Drug Delivery, 2016
View PDFchevron_right
Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation
Abdul Jabar
International Journal of Nanomedicine
View PDFchevron_right
Pteroyl-c-l-glutamate/Pluronic Ò F68 modified polymeric micelles loaded with docetaxel for targeted delivery and reduced toxicity
Dr. Shailendra S . Gurav
View PDFchevron_right
Methotrexate-Loaded Chitosan- and Glycolchitosan-Based Nanoparticles: A Promising Strategy for the Administration of the Anticancer Drug to Brain Tumors
Udo Bakowsky
AAPS PharmSciTech, 2011
View PDFchevron_right
Pteroyl-γ-l-glutamate/Pluronic® F68 modified polymeric micelles loaded with docetaxel for targeted delivery and reduced toxicity
Dr. Shailendra S . Gurav
Journal of Molecular Liquids, 2022
View PDFchevron_right
Silica-chitosan nanocomposite mediated pH-sensitive drug delivery
Kasturi Rokade
Journal of Drug Delivery Science and Technology, 2018
View PDFchevron_right